|
|
|
|
Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases
|
|
|
|
|
|
|
|
نویسنده
|
|
|
منبع
|
tunisie médicale - 2015 - دوره : 93 - شماره : 4 - صفحه:228 -230
|
|
چکیده
|
Background: perioperative chemotherapy containing 5fu,cisplatin ± docetaxel is one of the most active regimens in advanced gastric cancer. objective: to report epidemiological and clinical profile and therapeutic results of perioperative chemotherapy in locally advanced gastric cancer in tunisia methods: our retrospective study concerned patients with histologically confirmed advanced gastric cancer treated at the institute salah azaiez of tunis. they received 2-3 cycles / 3 weeks of neoadjuvant chemotherapy based on fp (5fu and cisplatin) or tpf (docetaxel-cisplatin-5fu). results: from 2010 to 2012,25 patients with a median age of 60 years and 7.3 sex-ratio received neoadjuvant chemotherapy. protocols used were tfp in 20 and fp in 5 patients,17 patients receiving more than 2 cycles. side effects were represented by mucositis grade 3 in 2 patients,neutropenia grade ¾ in 3 patients and renal failure in 5 patients. after neoadjuvant chemotherapy,we observed 40% of partial response and 20% of stable disease. six patients (24%) underwent surgery,curative in 4 (r0 in 3 cases) by total gastrectomy and d2 lymphadenectomy and palliative in 2 cases due to peritoneal carcinomatosis. with a median follow up of 16 months,median overall survival was 16 months (2-21 months). conclusion: probably due to the very bulky and advanced stages of our gastric cancer cases,neoadjuvant chemotherapy using fp±t showed no benefit in the treatment of locally advanced gastric cancer in tunisian patients. © 2011 la tunisie medicale. all rights reserved.
|
|
کلیدواژه
|
Gastric cancer; Neoadjuvant chemotherapy; Response; Surgery
|
|
آدرس
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|